A Plus Biotech monthly revenue
A Plus Biotech
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0.1B | +0.4% | +4.2% | NT$0.5B |
| May 2026 | Jun 17, 2026 | NT$0.1B | -7.1% | +27.2% | NT$0.4B |
| Apr 2026 | May 17, 2026 | NT$0.1B | +15.1% | +11.9% | NT$0.3B |
| Mar 2026 | Apr 17, 2026 | NT$0.1B | -0.6% | +16.2% | NT$0.2B |
| Feb 2026 | Mar 17, 2026 | NT$0.1B | +4.0% | +6.5% | NT$0.1B |
| Jan 2026 | — | NT$0.1B | — | +12.9% | NT$0.1B |
| Dec 2025 | — | NT$0.1B | — | -1.5% | NT$0.8B |
| Nov 2025 | — | NT$0.1B | — | +25.1% | NT$0.8B |
| Oct 2025 | — | NT$0.1B | — | -7.0% | NT$0.7B |
| Sep 2025 | — | NT$0.1B | — | +4.9% | NT$0.6B |
| Aug 2025 | — | NT$0.1B | — | +2.2% | NT$0.6B |
| Jul 2025 | — | NT$0.1B | — | +8.6% | NT$0.5B |
| Jun 2025 | — | NT$0.1B | — | +24.0% | NT$0.4B |
| May 2025 | — | NT$0.1B | — | +5.7% | NT$0.3B |
| Apr 2025 | — | NT$0.1B | — | +13.5% | NT$0.3B |
| Mar 2025 | — | NT$0.1B | — | -0.1% | NT$0.2B |
| Feb 2025 | — | NT$0.1B | — | +30.8% | NT$0.1B |
| Jan 2025 | — | NT$0.1B | — | +3.4% | NT$0.1B |
| Dec 2024 | — | NT$0.1B | — | +16.4% | NT$0.8B |
| Nov 2024 | — | NT$0.1B | — | +11.2% | NT$0.7B |
| Oct 2024 | — | NT$0.1B | — | +27.8% | NT$0.6B |
| Sep 2024 | — | NT$0.1B | — | +22.8% | NT$0.6B |
| Aug 2024 | — | NT$0.1B | — | +10.4% | NT$0.5B |
| Jul 2024 | — | NT$0.1B | — | +9.4% | NT$0.4B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-29. Source: Company websiteTaiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.